Location: Foreign Animal Disease Research
Project Number: 8064-32000-057-19
Start Date: Jul 01, 2011
End Date: Jun 30, 2014
To characterize Foot-and-Mouth Disease Virus (FMDV) isolates, samples will be collected and titrated using serotype-specific solid phase blocking enzyme linked immunosorbent assay (ELISAs) and by virus neutralization assays (VNTs). The vaccine matching approach will include the genetical characterization of the isolated viruses followed by determining antigenic relatedness of the viruses to known or putative new vaccine strains used in Uganda. Genetic diversity of the isolates will be determined by nucleotide sequencing of the capsid-coding region of FMDV. The outer capsid-coding sequence of FMDV will allow the prediction of antigenic relatedness to known or potential new vaccine strains and also the verification of serotypes. Serological antigenic matching tests will be carried out for the isolates against putative and known vaccine strains. Antisera will be prepared against putative vaccine strains. Where appropriate, currently used vaccine strains will be included in the test. In addition effort will be placed in developing capacity of performing VNT’s at Makerere University. Molecular and biochemical approaches like this are needed to address some of the limitations in the performance of current vaccines, in particular to their coverage. The implementation of these methodologies should contribute to the progressive global control and eradication of this devastating disease.